Multispectral Imaging Analysis of Skin Lesions in Patients with Neurofibromatosis Type 1

Abstract

Neurofibromatosis type 1 (NF1) is a rare disease, affecting around 1 in 3500 individuals in the general population. The rarity of the disease contributes to the scarcity of the available diagnostic and therapeutic approaches. Multispectral imaging is a non-invasive imaging method that shows promise in the diagnosis of various skin diseases. The device utilized for the present study consisted of four sets of narrow-band LEDs, including 526 nm, 663 nm, and 964 nm for diffuse reflectance imaging and 405 nm LEDs, filtered through a 515 nm long-pass filter, for autofluorescence imaging. RGB images were captured using a CMOS camera inside of the device. This paper presents the results of this multispectral skin imaging approach to distinguish the lesions in patients with NF1 from other more common benign skin lesions. The results show that the method provides a potential novel approach to distinguish NF1 lesions from other benign skin lesions.

A Misdiagnosed Familiar Brooke–Spiegler Syndrome: Case Report and Review of the Literature

“…A 28-year-old male with a clinical diagnosis of neurofibromatosis type 1 (NF1) pre sented to our clinic in 2018 with a progressively enlarging scalp mass [24]. The mass ap peared as an exophytic red papule, without ulceration, and the patient reported increasing discomfort associated with the tumor.…”